Human monoclonal antibodies for emerging infections

Human monoclonal antibodies for emerging infections

Tuesday, March 30, 2021 4:20 PM to 4:40 PM · 20 min. (Africa/Abidjan)

Antibodies

Infectious diseases

Presentation

Information

Single cell technologies for isolation of human mAbs to viruses
Molecular basis for high potency neutralization of viruses
Molecular basis of synergistic combinations of mAbs

James Crowe, Professor, Pediatrics and Pathology, Microbiology and Immunology, Director, Vanderbilt Vaccine Center

Twist BioscienceTwist Bioscience is powering the new bio-based economy with our synthetic DNA platform. We work in service of people who are changing the world for the better in fields such as medicine, agriculture, industrial chemicals and data storage. Our innovative silicon-based DNA Synthesis Platform and NGS offering provide precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. At Twist Bioscience, #WeMakeDNA. For more information, please visit www.twistbioscience.com.

Log in

See all the content and easy-to-use features by logging in